Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Repayments (2024 - 2025)

Historic Long-Term Debt Repayments for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q1 2025 value amounting to $9.6 million.

  • Tonix Pharmaceuticals Holding's Long-Term Debt Repayments rose 400638.3% to $9.6 million in Q1 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is N/A changed from last year.
  • As of Q1 2025, Tonix Pharmaceuticals Holding's Long-Term Debt Repayments stood at $9.6 million, which was up 400638.3% from $705000.0 recorded in Q4 2024.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Long-Term Debt Repayments registered a high of $9.6 million during Q1 2025, and its lowest value of $235000.0 during Q1 2024.